CTKB - Company ID 0001831915
The table below shows Cytek Biosciences, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $66.81M | $73.85M | $65.67M | $93.28M | $75.47M | $95.30M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $59.19M | $49.70M | $51.90M | $56.63M | $56.23M | $55.03M |
| Inventory | $52.37M | $52.25M | $49.79M | $51.65M | $49.49M | $45.35M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $378.94M |
| $377.93M |
| $379.30M |
| $388.49M |
| $382.82M |
| $380.50M |
| Property, plant & equipment | $20.61M | $20.80M | $20.47M | $18.05M | $18.35M | $17.83M |
| Goodwill | $16.69M | $16.69M | $16.69M | $16.70M | $16.71M | $16.68M |
| Total assets | $446.14M | $446.93M | $449.11M | $494.92M | $493.32M | $482.60M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $84.95M | $84.33M | $80.94M | $75.21M | $73.27M | $67.69M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $124.79M | $124.98M | $121.47M | $116.35M | $115.76M | $102.97M |
| Retained earnings | -$138.86M | -$132.76M | -$120.60M | -$57.66M | -$52.18M | -$46.60M |
| Total equity | $321.35M | $321.95M | $327.64M | $378.57M | $377.56M | $379.62M |